ZG16 is a lectin, and its reduced expression may impair host–microbiota interactions, increase the risk of pathogenic bacteria translocation, trigger chronic inflammation, and create an immunosuppressive environment conducive to tumor growth (36). Here, ZG16 is linked to neoplasm.